Definium Therapeutics, Inc. (MNMD)
NASDAQ · Healthcare
Definium Therapeutics, Inc. Long Term Debt 2020–2025
Definium Therapeutics, Inc. annual long term debt history from 2023 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Definium Therapeutics, Inc. long term debt as of December 31, 2025: 40.6M, a 85.68% increase year-over-year.
- Definium Therapeutics, Inc. long term debt for 2025 were 40.6M, a 85.68% increase from 2024.
- Definium Therapeutics, Inc. long term debt for 2024 were 21.9M, a 54.67% increase from 2023.
- Definium Therapeutics, Inc. long term debt for 2023 were 14.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Definium Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $41 |
| 2024 | $22 |
| 2023 | $14 |
Definium Therapeutics, Inc. Long Term Debt — FAQ
Definium Therapeutics, Inc. (MNMD) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNMD's long term debt history?
The chart and table above show Definium Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.